ARA 290 (Cibinetid)
Mechanism of action
What ARA 290 (Cibinetid) does in the body — step by step.
ARA 290 (cibinetide) is a short peptide derived from helix B of erythropoietin (EPO).
It binds to the so-called innate repair receptor (a complex of the EPO receptor and the β-common receptor subunit) without having the erythropoietic (blood-forming) action of EPO.
Tissue-protective and inflammation-modulating effects have been described.
Research status
How far along is the evidence?
Known risks
Without human data, safety statements are limited. What is known:
Cited studies
Chronological — links lead to the source.
Frequently asked questions
What is ARA 290 (Cibinetid)?+
ARA 290 (cibinetide) is a short peptide derived from helix B of erythropoietin (EPO).
What type of peptide is ARA 290 (Cibinetid)?+
ARA 290 (Cibinetid) belongs to the Other class.
What is ARA 290 (Cibinetid) used for?+
In research, ARA 290 (Cibinetid) has primarily been investigated in the context of: Recovery, Immunomodulation. These are research findings (evidence: early clinical studies), not proven benefits in humans and not a usage recommendation.
Is ARA 290 (Cibinetid) legal in Germany?+
ARA 290 (Cibinetid) is not approved as a medicine in Germany. Obtaining it outside clinical studies is legally problematic.
Is ARA 290 (Cibinetid) FDA-approved / legal in the US?+
No. ARA 290 (Cibinetid) is not FDA-approved as a drug in the US; it is mostly sold as a research chemical and not for human consumption.
Is ARA 290 (Cibinetid) legal in Canada?+
No. ARA 290 (Cibinetid) is not authorized by Health Canada and not intended for human consumption.
Where can I buy ARA 290 (Cibinetid)?+
Peptica sells nothing and names no sources. ARA 290 (Cibinetid) is "not approved" in Germany; obtaining unapproved substances outside clinical studies is illegal and carries quality and safety risks.
What is the dosage of ARA 290 (Cibinetid)?+
Peptica publishes no dosing. There are no approved dosing guidelines for ARA 290 (Cibinetid); figures circulating online stem from animal studies or anecdote, not from validated human protocols. This is not medical advice.
Is ARA 290 (Cibinetid) banned in sport (WADA)?+
ARA 290 (Cibinetid) is currently not on the WADA Prohibited List.
What are the known risks of ARA 290 (Cibinetid)?+
Documented risks include: Safety profile only from small, exploratory studies; Injection-site reactions possible. This is not a complete safety assessment and not medical advice — see the risks section for the full list.
How well researched is ARA 290 (Cibinetid)?+
The evidence is classified as “early clinical studies”. 2 studies are cited on this page.
What is the molecular weight of ARA 290 (Cibinetid)?+
ARA 290 (Cibinetid) has a molar mass of about 1257.3 Da.
Which peptides are related to ARA 290 (Cibinetid)?+
Closely related entries: Erythropoetin (EPO). A direct side-by-side comparison is available via the compare function.
Dossier
Legal · Structure · Sources.
ARA 290 (cibinetide) is not approved as a medicine; it is in clinical development. As it has no erythropoietic action, it is not in the same category as EPO; it is not WADA-listed. Obtaining it as a research chemical carries quality and safety risks.
Legal status varies by country and can change. This is not legal advice.
Methodology: Peptica compiles publicly available studies and regulatory information and assigns each statement an evidence level. Not medical advice. No warranty.